Mira Pharmaceuticals (MIRA) Short-term Investments (2025)

Mira Pharmaceuticals' (MIRA) quarterly Short-term Investments came in at $4.7 million in Q4 2025, down 4.32% quarter-over-quarter from $4.9 million in Q3 2025.

Mira Pharmaceuticals (MIRA) Short-term Investments (2025) Analysis & Trends

Mira Pharmaceuticals has disclosed Short-term Investments across 1 years of filings, most recently posting $4.7 million for Q4 2025.

  • Short-term Investments for Q4 2025 came in at $4.7 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $4.7 million (changed N/A YoY), and the FY2025 annual result was $4.7 million, changed N/A from the prior year.
  • Short-term Investments came in at $4.7 million for Q4 2025 at Mira Pharmaceuticals, down from $4.9 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $4.9 million in Q3 2025 to a low of $4.7 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Mira Pharmaceuticals 23.69 Mn 12.66 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 4.68 Mn
Sep 30, 2025 4.89 Mn